Access to anti-retroviral drugs, male in Indonesia
Indonesia: Access to anti-retroviral drugs, male was 44.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Indonesia, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, male in Indonesia is 44.0%, measured in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 33.3% on the previous year and up 388.9% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Indonesia peaked at 44.0% in 2024 and was at its lowest, 0.0%, in 2000.
Indonesia ranks 126th of 141 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Indonesia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 2.0% | — |
| 2007 | 2.0% | +0.0% |
| 2008 | 3.0% | +50.0% |
| 2009 | 4.0% | +33.3% |
| 2010 | 4.0% | +0.0% |
| 2011 | 5.0% | +25.0% |
| 2012 | 6.0% | +20.0% |
| 2013 | 7.0% | +16.7% |
| 2014 | 9.0% | +28.6% |
| 2015 | 11.0% | +22.2% |
| 2016 | 13.0% | +18.2% |
| 2017 | 16.0% | +23.1% |
| 2018 | 19.0% | +18.8% |
| 2019 | 22.0% | +15.8% |
| 2020 | 25.0% | +13.6% |
| 2021 | 27.0% | +8.0% |
| 2022 | 30.0% | +11.1% |
| 2023 | 33.0% | +10.0% |
| 2024 | 44.0% | +33.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.1% | 0.0% | 4.0% | 10 |
| 2010s | 11.2% | 4.0% | 22.0% | 10 |
| 2020s | 31.8% | 25.0% | 44.0% | 5 |
Countries ranked near Indonesia
- 125 Bangladesh 45.0% compare
- 126 Egypt 44.0% compare
- 128 Mongolia 42.0% compare
- 128 Philippines 42.0% compare
More gender data for Indonesia
- Child population (UN estimates and projections) 66,364 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.7373 % change on previous year (2030)
- Population 229,513 (2030)
- Working-age population (UN estimates and projections) 229,513 (2030)
- Population (UN estimates and projections), annual growth rate 1.05 % change on previous year (2030)
- Age population, age 00, female, interpolated 2.13 million (2025)
- Age population, age 00, male, interpolated 2.26 million (2025)
- Age population, age 01, female, interpolated 2.14 million (2025)
- Age population, age 01, male, interpolated 2.26 million (2025)
- Age population, age 02, female, interpolated 2.15 million (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Indonesia?
- Access to anti-retroviral drugs, male in Indonesia was 44.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Indonesia?
- The highest recorded value was 44.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Indonesia?
- The lowest recorded value was 0.0% in 2000.
- How does Indonesia rank for access to anti-retroviral drugs, male?
- Indonesia ranks 126th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Indonesia?
- Over the last ten years it is up 388.9%. The long-run trend across the full record is volatile.
- Where does this Indonesia data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.